Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis

• Κύριοι συγγραφείς: Yasmin de Souza Lima Bitar (Συγγραφέας), Mansueto Gomes Neto (Συγγραφέας), Jose Admirço Lima Filho (Συγγραφέας), Larissa Vitória Pereira (Συγγραφέας), Kethyren Santos Oliveira Travassos (Συγγραφέας), Kevan M. Akrami (Συγγραφέας), Leonardo Roever (Συγγραφέας), Andre Rodrigues Duraes (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Adis, Springer Healthcare, 2019-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Introduction New oral anticoagulants (NOACs) are approved for use in nonvalvular atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of NOACs compared with warfarin in AF and valvular heart disease (VHD). Methods We identified randomized controlled tria...